GO
Loading...

NPS Pharma CEO: Netpara will have greater potential than Gattex

Thursday, 10 Oct 2013 | 2:23 PM ET

Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Netpara and the solid performance of its stock.